Latest Strategic Initiatives News

Botanix Pharmaceuticals has secured a US$30 million debt facility from Kreos Capital, bolstering its financial position to commercialize Sofdra™ and pursue platform expansion opportunities.

Dateline Resources has upgraded its U.S. trading status to OTCQB, enhancing liquidity and investor access as interest surges around its Colosseum Gold-REE Project in California.

Queste Communications reported a $3 million inflow from an iron-ore royalty termination in May 2025, bolstering its cash reserves to over $4 million despite ongoing operating cash outflows.

Lanthanein Resources is set to raise $2.4 million through a placement and a fully underwritten rights issue, while proposing a strategic name change and share consolidation to streamline its capital structure.

QX Resources has secured a farm-out deal transferring a 75% interest in its Western Shaw iron ore rights, with partners committing $1 million to exploration, while retaining a royalty stream.

The Australian Government has delayed the rollout of the new Aged Care Act 2024, postponing key funding reforms from July to November 2025. Regis Healthcare acknowledges the delay and promises ongoing updates.

COSOL Limited anticipates solid revenue and earnings growth for FY25 despite some contract timing setbacks, with a promising outlook for FY26 driven by data analytics and managed services expansion.

Dominion Income Trust 1 (ASX – DN1) has announced a $45 million placement at $101 per unit, aiming to enhance fund diversification and liquidity without impacting net asset value.

HITIQ Limited has pushed back the closing date for its entitlement issue offer to June 20, adjusting the timeline for its capital raising efforts.

High-Tech Metals Limited has successfully completed a modest capital raise through a non-renounceable entitlement offer, issuing shares at $0.15 each alongside free attaching options. The company now holds discretion over a significant shortfall placement, which could influence its capital structure in the coming months.

Codeifai Limited has locked in $570,000 through a discounted share placement, aiming to fuel its digital platform growth and strategic initiatives.

AdAlta Limited has successfully raised $1.1 million through a renounceable rights issue, positioning itself to advance key CAR-T licensing and immunotherapy projects. The capital injection underscores confidence from leadership and investors amid a transformative phase for the biotech company.